STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.7, 2007-07, pp. : 869-880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-17 cytokine/receptor families: emerging targets for the modulation of inflammatory responses

By Dumont Francis J

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 287-303

Informa Healthcare

Access to resources Recommend Favorite

Small Molecule Inhibitors of Stat3 Signaling Pathway

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-01 ,pp. : 91-107

Bentham Science Publishers

Access to resources Recommend Favorite

Innate Inflammatory Responses in Stroke: Mechanisms and Potential Therapeutic Targets

Current Medicinal Chemistry, Vol. 21, Iss. 18, 2014-06 ,pp. : 2076-2097

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy

Current Drug Targets, Vol. 15, Iss. 14, 2014-12 ,pp. : 1341-1353

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

Current Drug Targets, Vol. 9, Iss. 5, 2008-05 ,pp. : 369-374

Bentham Science Publishers

Access to resources Recommend Favorite